The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_000314.6(PTEN):c.-1142C>T

CA151480

127661 (ClinVar)

Gene: KLLN
Condition: PTEN hamartoma tumor syndrome
Inheritance Mode: Autosomal dominant inheritance
UUID: b49fa554-1a60-419c-8931-6cdc5564285c
Approved on: 2018-04-06
Published on: 2018-12-10

HGVS expressions

NM_000314.6:c.-1142C>T
NM_000314.6(PTEN):c.-1142C>T
NM_001126049.1:c.-840G>A
ENST00000371953.7:c.-1143C>T
ENST00000445946.3:c.-840G>A
NC_000010.11:g.87863327C>T
CM000672.2:g.87863327C>T
NC_000010.10:g.89623084C>T
CM000672.1:g.89623084C>T
NC_000010.9:g.89613064C>T
NG_007466.2:g.4890C>T
NG_033079.1:g.5111G>A

Likely Benign

Met criteria codes 2
BS1 BP2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
PTEN VCEP
PTEN c.-1142C>T (NC_000010.10:g.89623084C>T) meets criteria to be classified as likely benign for PTEN Hamartoma Tumor syndrome in an autosomal dominant manner using modified ACMG criteria (PMID 30311380). Please see a summary of the rules and criteria codes in the “PTEN ACMG Specifications Summary” document (assertion method column). BS1: Allele frequency of 0.0049 (0.49%, 8/1622 alleles) in the East Asian subpopulation of the gnomAD cohort. (PMID 27535533) BP2: Observed in trans with a pathogenic or likely pathogenic PTEN variant, at least three observations in cis and/or phase unknown with different pathogenic/likely pathogenic PTEN variants. (Internal laboratory contributors SCV000187279.1, SCV000149465.6)
Met criteria codes
BS1
Allele frequency 0.0049 (8/1622, 0.49%) in East Asian individuals in gnomAD.
BP2
Multiple co-occurrences with pathogenic/likely pathogenic PTEN variants. 1 confirmed in trans, 3 with phase unknown.
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.